参考文献/References:
[1] Ota M, Iwasaki Y, Harada H, et al. Efficacy of intensive immunosuppression in exacerbated rheumatoid arthritis-associated interstitial lung disease[J]. Mod Rheumatol,2017,27(1): 22-28.
[2] Yazdani A. Singer LG, Strand V, et al. Survival and quality of life in rheumatoid arthritis-associated interstitial lung disease after lung transplantation[J]. J Heart Lung Transplant,2014,33(5): 514-520.
[3] Lasithiotaki I, Giannarakis I, Tsitoura E, et al. NLRP3 inflammasome expression in idiopathic pulmonary fibrosis and rheumatoid lung[J]. Eur Respir J,2016,47(3): 910-918.
[4] Iguchi-Hashimoto M, Hashimoto M, Fujii T, et al. The association between serious infection and disease outcome in patients with rheumatoid arthritis[J]. Clin Rheumatol,2016,35(1): 213-218.
[5] Perez-Dorame R, Mejia M, Mateos-Toledo H, et al. Rheumatoid arthritis-associated interstitial lung disease: lung inflammation evaluated with high resolution computed tomography scan is correlated to rheumatoid arthritis disease activity[J]. Reumatol Clin,2015,11(1): 12-16.
[6] Natalini JG, Swigris JJ, Morisset J, et al. Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease[J]. Respir Med,2017,127: 1-6.
[7] 戴 璐, 宋欣丽, 王 健. 青藤碱联合甲氨蝶呤对类风湿性关节炎患者血清炎症因子的影响及治疗安全性分析[J]. 陕西医学杂志,2018,47(12):1581-1583.
[8] Bernstein EJ, Barr RG, Austin JHM, et al. Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: the multi-ethnic study of atherosclerosis[J]. Thorax,2016,71(12): 1082-1090.
[9] White ES, Xia M, Murray S, et al. Plasma surfactant protein-D, matrix metalloproteinase-7, and osteopontin index distinguishes idiopathic pulmonary fibrosis from other idiopathic interstitial pneumonias[J]. Am J Respir Crit Care Med,2016,194(10): 1242-1251.
[10] Samara KD, Trachalaki A, Tsitoura E, et al. Upregulation of citrullination pathway: From autoimmune to idiopathic lung fibrosis[J]. Respir Res,2017,18(1): 218.
[11] Walsh SLF, Maher TM, Kolb M, et al. Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study[J]. Eur Respir J,2017,50(2):370-371.
[12] Morisset J, Vittinghoff E, Lee BY, et al. The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease[J]. Respir Med,2017,127: 51-56.
[13] Wang T, Zheng XJ, Ji YL, et al. Tumour markers in rheumatoid arthritis-associated interstitial lung disease[J]. Clin Exp Rheumatol,2016,34(4): 587-591.
[14] Hwang J, Song JU, Ahn JK. Decline of pulmonary function is associated with the presence of rheumatoid factor in Korean health screening subjects without clinically apparent lung disease: A cross-sectional study[J]. Medicine (Baltimore),2016,95(19): e3668.
[15] 丁 薇，赵云峰，陆海雯，等. 合并类风湿关节炎对支气管扩张症的影响及相关因素[J]. 中华结核和呼吸杂志，2017，40(1): 24-28.
[16] 李 铭, 高 云, 于 赟，等. 胎盘多肽、鹿瓜多肽联合抗风湿类药物治疗类风湿性关节炎临床观察[J]. 陕西医学杂志，2016，45(10): 1413-1414.
[17] 孟 鑫. 慢性阻塞性肺疾病合并肺间质纤维化中医证候分布特点研究[D]. 山东中医药大学. 2018.
相似文献/References:
[1]孙芳芳,张 静△,范秀风.类风湿关节炎合并心血管损伤危险因素研究*[J].陕西医学杂志,2019,(10):1305.
[2]王 颖,白 琳,张 洁,等.抑制炎性细胞因子与类风湿关节炎合并急性心肌梗死患者颈动脉斑块相关性研究*[J].陕西医学杂志,2019,(12):1679.
[3]刘昌莲,贺冬冬,李晓明,等.艾拉莫德治疗类风湿关节炎疗效及对患者免疫炎症因子水平和骨代谢指标的影响*[J].陕西医学杂志,2020,49(5):603.
LIU Changlian,HE Dongdong,LI Xiaoming,et al.Clinical efficacy of Iguratimod in the treatment of rheumatoid arthritis and its effect on the levels of immune inflammatory factors and the indexes of bone metabolism[J].,2020,49(6):603.
[4]刘兆宜,沈洲立,岳跃兵,等.类风湿关节炎并发动脉粥样硬化相关性研究进展*[J].陕西医学杂志,2020,49(11):1534.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.043]
LIU Zhaoyi,SHEN Zhouli,YUE Yuebing,et al.Research progress on the correlation between rheumatoid arthritis and atherosclerosis[J].,2020,49(6):1534.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.043]
[5]李长超,柴艳梅,刘 丹,等.类风湿关节炎患者血清IL-13水平表达及对外周血单个核细胞中Th17细胞亚群分化的影响[J].陕西医学杂志,2021,50(2):197.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.018]
LI Changchao,CHAI Yanmei,LIU Dan,et al.Expression of serum IL-13 in patients with rheumatoid arthritis and its effect on differentiation of Th17 cell subsets in PBMC[J].,2021,50(6):197.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.018]
[6]安 新,冯 超,高利常.类风湿关节炎患者血清白细胞介素-32、白细胞介素-17和白细胞介素-10表达水平及临床意义[J].陕西医学杂志,2021,50(12):1585.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.030]
AN Xin,FENG Chao,GAO Lichang.Expression levels of serum interleukin-32,interleukin-17 and interleukin-10 in patients with rheumatoid arthritis and their clinical significance[J].,2021,50(6):1585.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.030]
[7]杨 婧,何家锐,孙红兵,等.沙利度胺对类风湿关节炎滑膜细胞及外周血单个核细胞分泌肿瘤坏死因子-α和血管内皮生长因子的影响及机制研究[J].陕西医学杂志,2022,51(12):1501.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.008]
YANG Jing,HE Jiarui,SUN Hongbing,et al.Effects of thalidomide on secretion of TNF-α and VEGF in fibroblast-like synoviocytes and peripheral blood mononuclear cells in patients with rheumatoid arthritis and its mechanism[J].,2022,51(6):1501.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.008]
[8]王小蕊,李文倩,解友邦,等.托法替尼联合传统DMARDs类药物治疗类风湿性关节炎临床效果观察[J].陕西医学杂志,2023,52(12):1728.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.022]
WANG Xiaorui,LI Wenqian,XIE Youbang,et al.Clinical effect of tofacitinib combined with traditional DMARDs in treatment of rheumatoid arthritis[J].,2023,52(6):1728.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.022]
[9]王一晨,谷慧敏,陈宇华,等.孟德尔随机化在类风湿关节炎相关研究中的应用[J].陕西医学杂志,2024,(11):1562.[doi:DOI:10.3969/j.issn.1000-7377.2024.11.027]
WANG Yichen,GU Huimin,CHEN Yuhua,et al.Application of Mendelian randomization in rheumatoid arthritis-related research[J].,2024,(6):1562.[doi:DOI:10.3969/j.issn.1000-7377.2024.11.027]
[10]康 聪,杨 光,王 芳,等.牛膝多糖调控转移相关蛋白1/核因子-κB通路对类风湿关节炎大鼠踝关节破坏的影响实验研究[J].陕西医学杂志,2024,(12):1624.[doi:DOI:10.3969/j.issn.1000-7377.2024.12.007]
KANG Cong,YANG Guang,WANG Fang,et al.Effects of achyranthan polysaccharides regulating MTA1/NF-κB pathway on destruction of ankle joint in rats with rheumatoid arthritis[J].,2024,(6):1624.[doi:DOI:10.3969/j.issn.1000-7377.2024.12.007]